Condition hub · vitiligo

Vitiligo: understand the condition and prepare your next conversation.

Use this hub to orient yourself, find the current phototherapy evidence, and see what SteadySkin is building next.

The most useful thing here

Walk in with the right questions.

Save the ones that fit. They remain in this browser until you clear them.

  • What are we trying to change with this plan, and how will we decide whether it is helping?Saving keeps this on your device and needs JavaScript, which is off in this browser.
  • Which options should we compare before I make a decision?Saving keeps this on your device and needs JavaScript, which is off in this browser.
  • What should I record between visits so you can see what actually happened?Saving keeps this on your device and needs JavaScript, which is off in this browser.

Find the right depth

The treatment landscape.

No ranked ladder and no implied completeness. Each row says where the depth lives.

What the published evidence establishes

A narrow starting point, not a personal forecast.

Narrowband UVB is used for skin conditions including vitiligo and psoriasis. [1] [2] That does not establish whether it is appropriate for you or how your skin will respond.

ConfidenceReasonably supportedLast checked by us29 Jul 2026Review statusPublished with limitations

If phototherapy is on the table

The decision is only the beginning.

SteadySkin is building the practical path around the clinical conversation.

Available nowUnderstand narrowband UVBRead the sourced guide →
Next content buildCompare home and clinicConvenience, supervision, cost, and time—held together
Next content buildGet accessCoverage rules, prior authorization, denials, and appeals
Next content buildOwn the long tailDelivery, routines, refill codes, lamps, manuals, and support

Sources

  1. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022

    British Journal of Dermatology (Goulden V, et al.)

    Regulatory / guidelineIndependent

    Published
    2022-09-01
    Last checked by us
    2026-07-29

    What this source does and does not support

    Supports that therapeutic narrowband UVB lamps have an emission spectrum peaking near 311–313 nm, and that this narrow band was selected because it is the most effective part of the UVB spectrum for treating psoriasis. It is a clinical guideline for clinicians administering phototherapy; it does not establish any home-use dose, and this site never reproduces its dosing schedules.

    Read the source
  2. Phototherapy — NB-UVB (patient information leaflet)

    British Association of Dermatologists

    Patient educationIndependent

    Published
    2022-06-01
    Last checked by us
    2026-07-29

    What this source does and does not support

    Supports, in plain patient-facing language, that narrowband UVB uses a small part of the UVB spectrum and is used for skin conditions including psoriasis, eczema and vitiligo. As patient-education material it is context, not primary evidence, for any efficacy claim. Its review date is June 2025, so re-verify before relying on it past then.

    Read the source

When you are ready to record

The app starts with vitiligo.

Everything on this website works without it.

Join the waitlist

Hear when SteadySkin is available

We use your address for one thing: telling you when the app is out. No newsletter, and we never sell or share it. Nothing about your condition or what you read here is attached to it. You will get a confirmation email — click the link in it to finish joining. Your address is stored by Buttondown, who send the mail on our behalf and show the confirmation page.

One email when it is out. Nothing else, ever.